Has John Birgiolas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,671 in general payments to John Birgiolas, MD across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Birgiolas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Birgiolas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Birgiolas, MD

Interventional Pain Medicine · Ionia, MINPI 1639309388

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.

$2,671in general payments, 2019–2025

Across 92 payments — averaging $29.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$547
Abbott$326
Boston Scientific$315
AbbVie$226
Teva Pharmaceuticals USA, Inc.$143
Globus Medical$137
plus $977 from 17 others

What the payments were for

Food & beverage$2,671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	10	$547
Abbott	8	$326
Boston Scientific	8	$315
AbbVie(2 entities)	12	$226
Teva Pharmaceuticals USA, Inc.	8	$143
Globus Medical	5	$137
Saluda Medical Americas, Inc.	1	$125
Pfizer	6	$123
Collegium Pharmaceutical, Inc.	6	$113
Medtronic(2 entities)	4	$80
Assertio Therapeutics, Inc.	5	$80
Novartis	3	$66
Vertiflex, Inc.	1	$58
Painteq LLC	1	$57
Spinal Simplicity, LLC	1	$46
Lilly USA, LLC	3	$43
Supernus Pharmaceuticals, Inc.	2	$39
Relievant Medsystems, Inc.	2	$37
Hydrocision, Inc.	1	$35
Vertical Pharmaceuticals, LLC	2	$26
Amgen	1	$22
SPR Therapeutics, Inc	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,671 in reported general payments places this provider in the 55th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan →

Medicare billing

Part B allowed, 2024

$173,205

Medicare patients

226

Services billed

4,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	1,049	$17,840
Emgality SyringeGalcanezumab-Gnlm	14	$9,460
Morphine Sulfate ErMorphine Sulfate	193	$4,763
Gabapentin	359	$4,671
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	194	$4,484
Fentanyl	48	$4,325
Baclofen	148	$2,350
Pregabalin	142	$2,173
Tizanidine Hcl	224	$2,023
Tramadol Hcl	148	$1,503
Oxycodone Hcl	58	$1,455
Naloxone Hcl	17	$1,226
Nabumetone	33	$777
Duloxetine Hcl	53	$633
Amitriptyline Hcl	35	$500

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Ionia

Ryan PollinaSaint Clair Shores$144K
Ariel MajjhooMonroe$124K
Chad BrummettAnn Arbor$109K
Anand ThakurClinton Township$102K
Evan PeskinFlint$72K
Richard FerroLansing$31K
John ChatasAnn Arbor$29K
Bryant IttiaraAllen Park$28K
Fadi DellyWyandotte$25K
Vincent RampersaudFlint$24K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →